IGHE and gastroesophageal reflux disease: Acid blocker/motility agents for infant gastroesophageal reflux (GER) (Q1), urine samples in respiratory tract infections (RTIs) (Q8), IgE tests for food allergies without relevant medical history (Q10), prolonged antibiotic use in newborns (Q6), continuous hospitalization ininfants after negative bacterial culture results (Q15), and IV antibiotic therapy in well-appearing newborn with isolated risk for sepsis (Q18) were other items which ranked among the top 10 topics.